Eli Lilly launches Mounjaro, the much-awaited diabetes drug, in India. It is priced at ₹3,500 for 2.5 mg. Mounjaro and ...

Fact checked by Nick Blackmer “Microdosing” GLP-1 drugs like Ozempic is gaining attention on social media, but doctors say it ...

While the number of prescription fills for GLP-1 receptor agonists has continued to increase, health Insurance coverage for ...

More and more people are microdosing Ozempic, a popular weight loss drug, due to high costs and uncomfortable side effects.

among other functions (some drugs like tirzepatide mimic both GLP-1 and other related hormones). Does Ozempic Really Cause Thyroid Cancer? What the Science Actually Says As groundbreaking as these ...

US-based Lilly and Danish Novo Nordisk have seen skyrocketing global demand for their innovative weight-loss drugs, with ...

A healthcare professional reviews your visit and schedules a consultation to determine whether Ozempic, or another GLP-1 medication, is appropriate. If you and the healthcare professional decide ...

or 15 mg, or Ozempic at a dose of 1 mg. At 40 weeks, the mean HbA1c level with Mounjaro at a dose of 5 mg, 10 mg, and 15 mg was reduced by 2.01%, 2.24%, and 2.30%, respectively, compared to a ...

As Ozempic and other GLP-1 drugs explode in popularity, driven by their off-label use for rapid weight loss and viral social media trends, the pharmaceutical industry faces unprecedented challenges.

The rise in diet-related diseases has changed how US consumers view food, with many Americans becoming more conscious of what they’re putting in their bodies and has led to an explosive growth in ...